OpenURL Connection Search

Select item for more details and to access through your institution.

High-dose thiotepa and etoposide-based regimens with autologous hematopoietic support for high-risk or recurrent CNS tumors in children and adults.
Published in:
Bone Marrow Transplantation, 1998, v. 22, n. 7, p. 661, doi. 10.1038/sj.bmt.1701408
By:
- Papadopoulos, K P;
- Garvin, J H;
- Fetell, M;
- Vahdat, L T;
- Garrett, T J;
- Savage, D G;
- Balmaceda, C;
- Bruce, J;
- Sisti, M;
- Isaacson, S;
- De LaPaz, R;
- Hawks, R;
- Bagiella, E;
- Antman, K H;
- Hesdorffer, C S
Publication type:
Article
Ganglioneuroma presenting with differentiated skeletal metastases. Report of a case.
Published in:
1984
By:
- Garvin, James H.;
- Lack, Ernest E.;
- Berenberg, William;
- Frantz, Christopher N.;
- Garvin, J H Jr;
- Lack, E E;
- Berenberg, W;
- Frantz, C N
Publication type:
journal article
Pediatric allo-SCT for malignant and non-malignant diseases: impact on health-related quality of life outcomes.
Published in:
Bone Marrow Transplantation, 2013, v. 48, n. 6, p. 787, doi. 10.1038/bmt.2012.217
By:
- Oberg, J A;
- Bender, J G;
- Morris, E;
- Harrison, L;
- Basch, C E;
- Garvin, J H;
- Sands, S A;
- Cairo, M S
Publication type:
Article
The pharmacokinetics and safety of twice daily i.v. BU during conditioning in pediatric allo-SCT recipients.
Published in:
Bone Marrow Transplantation, 2013, v. 48, n. 1, p. 19, doi. 10.1038/bmt.2012.105
By:
- Le Gall, J B;
- Milone, M C;
- Waxman, I M;
- Shaw, L M;
- Harrison, L;
- Duffy, D;
- van de Ven, C;
- Militano, O;
- Geyer, M B;
- Morris, E;
- Bhatia, M;
- Satwani, P;
- George, D;
- Garvin, J H;
- Bradley, M B;
- Schwartz, J;
- Baxter-Lowe, L A;
- Cairo, M S
Publication type:
Article
A pilot study of reduced toxicity conditioning with BU, fludarabine and alemtuzumab before the allogeneic hematopoietic SCT in children and adolescents.
Published in:
Bone Marrow Transplantation, 2011, v. 46, n. 6, p. 790, doi. 10.1038/bmt.2010.209
By:
- Styczynski, J.;
- Tallamy, B.;
- Waxman, I.;
- van de Ven, C.;
- Milone, M. C.;
- Shaw, L. M.;
- Harrison, L.;
- Morris, E.;
- Satwani, P.;
- Bhatia, M.;
- George, D.;
- Bradley, M. B.;
- Garvin, J. H.;
- Schwartz, J.;
- Baxter-Lowe, L. A.;
- Cairo, M. S.
Publication type:
Article
A double-blind randomized placebo-controlled study of oral glutamine in the prevention of mucositis in children undergoing hematopoietic stem cell transplantation: a pediatric blood and marrow transplant consortium study.
Published in:
Bone Marrow Transplantation, 2005, v. 36, n. 7, p. 611, doi. 10.1038/sj.bmt.1705084
By:
- Aquino, V. M.;
- Harvey, A. R.;
- Garvin, J. H.;
- Godder, K. T.;
- Nieder, M. L.;
- Adams, R. H.;
- Jackson, G. B.;
- Sandler, E. S.
Publication type:
Article
Sequential myeloablative autologous stem cell transplantation and reduced intensity allogeneic hematopoietic cell transplantation is safe and feasible in children, adolescents and young adults with poor-risk refractory or recurrent Hodgkin and non-Hodgkin lymphoma
Published in:
Leukemia (08876924), 2015, v. 29, n. 2, p. 448, doi. 10.1038/leu.2014.194
By:
- Satwani, P;
- Jin, Z;
- Martin, P L;
- Bhatia, M;
- Garvin, J H;
- George, D;
- Chaudhury, S;
- Talano, J;
- Morris, E;
- Harrison, L;
- Sosna, J;
- Peterson, M;
- Militano, O;
- Foley, S;
- Kurtzberg, J;
- Cairo, M S
Publication type:
Article

Found: 7

High-dose thiotepa and etoposide-based regimens with autologous hematopoietic support for high-risk or recurrent CNS tumors in children and adults.

Ganglioneuroma presenting with differentiated skeletal metastases. Report of a case.

Pediatric allo-SCT for malignant and non-malignant diseases: impact on health-related quality of life outcomes.

The pharmacokinetics and safety of twice daily i.v. BU during conditioning in pediatric allo-SCT recipients.

A pilot study of reduced toxicity conditioning with BU, fludarabine and alemtuzumab before the allogeneic hematopoietic SCT in children and adolescents.

A double-blind randomized placebo-controlled study of oral glutamine in the prevention of mucositis in children undergoing hematopoietic stem cell transplantation: a pediatric blood and marrow transplant consortium study.

Sequential myeloablative autologous stem cell transplantation and reduced intensity allogeneic hematopoietic cell transplantation is safe and feasible in children, adolescents and young adults with poor-risk refractory or recurrent Hodgkin and non-Hodgkin lymphoma